[연합뉴스TV 캡처]
(Seoul = Yonhap News) Reporter Kyu-bin Hong = Professor Kim Do-kyung of Kyunghee University has developed the world’s first technology for diagnosing cervical cancer with urine.
If the technology is commercialized, it is expected that the diagnosis time and cost will be significantly reduced compared to the existing procedures that require genetic, colposcopy, and biopsy.
On the 14th, Kyung Hee University announced that Professor Kim’s thesis containing these contents was published in the international scientific journal ‘Sensors and Actuators: B Chemical.’
The key to the result of this study is that it is possible to selectively detect ‘cysteine’, a substance considered a biomarker for cancer diagnosis, in urine.
In the past, it was difficult to selectively detect cysteine because its structure is similar to that of other biomaterials, but thanks to the ‘Fluorescent Probe’ developed by Professor Kim, cysteine can be detected quickly and accurately.
The school explained that this technology can be commercialized at the current level as the diagnostic potential has already been confirmed in 1,700 clinical samples.
Professor Kim said, “We will continue to work hard so that it can be widely used for early diagnosis of cancer and follow-up following treatment.”
(Seoul = Yonhap News) The left side shows the fluorescence spectrum from normal urine, and the right side shows the fluorescence spectrum from the urine of a cervical cancer patient. It can be seen that the fluorescence spectrum is dramatically increased following treatment with the fluorescent molecular probe. 2022.3.14 [경희대 제공. 재판매 및 DB 금지]
Report on Kakao Talk okjebo
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2022/03/14 18:36 Send
